754 Recruiting Trials

Clinical Trials
in Nebraska

Browse 754 recruiting clinical trials currently enrolling participants in Nebraska. Search by condition to find trials you may qualify for, at no cost.

Showing 15 of 754 recruiting trials in Nebraska

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
PHASE2 Anchorage, Alaska +4 sites · Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
PHASE3 Anchorage, Alaska +4 sites · Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NA Tucson, Arizona +4 sites · Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication
Recruiting
Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy
PHASE3 Chandler, Arizona +4 sites · Open Tíbia Fracture, Open tíbia Fracture
Recruiting
Recruiting
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
PHASE3 Phoenix, Arizona +4 sites · Metastatic Dedifferentiated Liposarcoma, Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Recruiting
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
PHASE3 Saint Augustine, Florida +4 sites · Human Papilloma Virus (HPV), Warts
Recruiting
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
PHASE2 Little Rock, Arkansas +4 sites · Non-small Cell Lung Cancer
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
PHASE2 Birmingham, Alabama +4 sites · Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma
Recruiting
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy
Recruiting